ALDX
Price
$2.18
Change
+$0.02 (+0.93%)
Updated
May 9 closing price
Capitalization
130.16M
One day until earnings call
ANEB
Price
$1.04
Change
-$0.03 (-2.80%)
Updated
May 9 closing price
Capitalization
42.73M
One day until earnings call
Ad is loading...

ALDX vs ANEB

Header iconALDX vs ANEB Comparison
Open Charts ALDX vs ANEBBanner chart's image
Aldeyra Therapeutics
Price$2.18
Change+$0.02 (+0.93%)
Volume$1.09M
Capitalization130.16M
Anebulo Pharmaceuticals
Price$1.04
Change-$0.03 (-2.80%)
Volume$2.75K
Capitalization42.73M
ALDX vs ANEB Comparison Chart
Loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALDX vs. ANEB commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Hold and ANEB is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (ALDX: $2.18 vs. ANEB: $1.04)
Brand notoriety: ALDX and ANEB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 52% vs. ANEB: 8%
Market capitalization -- ALDX: $130.16M vs. ANEB: $42.73M
ALDX [@Biotechnology] is valued at $130.16M. ANEB’s [@Biotechnology] market capitalization is $42.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 1 FA rating(s) are green whileANEB’s FA Score has 0 green FA rating(s).

  • ALDX’s FA Score: 1 green, 4 red.
  • ANEB’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALDX and ANEB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 4 TA indicator(s) are bullish while ANEB’s TA Score has 4 bullish TA indicator(s).

  • ALDX’s TA Score: 4 bullish, 5 bearish.
  • ANEB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ANEB is a better buy in the short-term than ALDX.

Price Growth

ALDX (@Biotechnology) experienced а -22.42% price change this week, while ANEB (@Biotechnology) price change was -9.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.25%. For the same industry, the average monthly price growth was +9.40%, and the average quarterly price growth was -13.49%.

Reported Earning Dates

ALDX is expected to report earnings on Aug 08, 2025.

ANEB is expected to report earnings on Sep 17, 2025.

Industries' Descriptions

@Biotechnology (-6.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALDX($130M) has a higher market cap than ANEB($42.7M). ANEB YTD gains are higher at: -38.095 vs. ALDX (-56.313). ANEB has higher annual earnings (EBITDA): -7.43M vs. ALDX (-53.68M). ALDX has more cash in the bank: 101M vs. ANEB (15M). ALDX (0) and ANEB (0) have equivalent revenues.
ALDXANEBALDX / ANEB
Capitalization130M42.7M304%
EBITDA-53.68M-7.43M723%
Gain YTD-56.313-38.095148%
P/E RatioN/AN/A-
Revenue00-
Total Cash101M15M673%
Total Debt15.3MN/A-
FUNDAMENTALS RATINGS
ALDX: Fundamental Ratings
ALDX
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALDXANEB
RSI
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 12 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Ad is loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA298.2613.44
+4.72%
Tesla
GME27.540.76
+2.84%
GameStop Corp
BTC.X104696.3300001725.468800
+1.68%
Bitcoin cryptocurrency
AAPL198.531.04
+0.53%
Apple
SPY564.34-0.72
-0.13%
SPDR® S&P 500® ETF

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with GSGTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
+0.93%
GSGTF - ALDX
56%
Loosely correlated
N/A
CGON - ALDX
39%
Loosely correlated
-1.62%
PLRX - ALDX
38%
Loosely correlated
-3.42%
ARVN - ALDX
37%
Loosely correlated
-2.94%
MGTX - ALDX
32%
Poorly correlated
-0.91%
More

ANEB and

Correlation & Price change

A.I.dvisor tells us that ANEB and ABCZF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANEB and ABCZF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANEB
1D Price
Change %
ANEB100%
-2.80%
ABCZF - ANEB
31%
Poorly correlated
N/A
ALDX - ANEB
28%
Poorly correlated
+0.93%
ACHL - ANEB
25%
Poorly correlated
N/A
SRPT - ANEB
24%
Poorly correlated
-0.68%
RLAY - ANEB
23%
Poorly correlated
N/A
More